Apoorva Gomber, MBBS, MD, MPH
Dr. Apoorva Gomber is a physician and global health advocate dedicated to strengthening clinical care for type 1 diabetes and advancing equitable access to diabetes technology in low-resource settings. As the Associate Advocacy Director at the Center for Integration Science inGlobal Health Equity and the NCDI Poverty Network, she works on the advancement of implementation science and integration of type 1 diabetes care and other severe chronic noncommunicable diseases among children into primary healthcare systems, ensuring that life-saving treatment reaches the most underserved communities.
Dr. Gomber’s work spans research, policy, and advocacy, with a particular focus on health disparities in diabetes care. She has led initiatives to improve access to insulin, enhance diabetes education, and drive innovations and community-led efforts in diabetes technology for low- and middle-income countries. She was one of the Technical Advisory Group Experts on Diabetes (TAG-D) for the Global Diabetes Compact at the World Health Organization (2021–2023) and continues to contribute to global health research that informs policy and strengthens diabetes care delivery.
Her long-standing commitment to Beyond Type 1 began in 2017. In 2018, she ran the New York City Marathon to fundraise for the organization, and she later played a key role in launching the Beyond Type 1 India chapter of Type 1 Run. Around the same time, she co-founded Diabetes India Youth in Action, which started as a patient-led advocacy initiative and has since evolved into a diverse network of peer-led diabetes communities across India. This transformation reflects the success of grassroots activism and community-driven efforts in reshaping the narrative of childhood diabetes care in the country.
Dr. Gomber was also recently appointed as one of the Emerging Leaders Council Members at the American Heart Association, where she contributes to advancing cardiovascular and metabolic health equity. She holds a Master of Public Health from Harvard T.H. Chan School of Public Health and continues to work at the intersection of clinical care, research, and advocacy to improve diabetes management globally. Beyond her professional work, she is an avid runner, traveler, and advocate for the power of community in driving meaningful change for people living with type 1 diabetes.